Phase II study of topotecan and paclitaxel for recurrent, persistent, or metastatic cervical carcinoma. [electronic resource]
Producer: 20040323Description: 635-8 p. digitalISSN:- 0090-8258
- Adenocarcinoma -- drug therapy
- Adult
- Aged
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Carcinoma, Squamous Cell -- drug therapy
- Female
- Humans
- Middle Aged
- Neoplasm Recurrence, Local -- drug therapy
- Paclitaxel -- administration & dosage
- Topotecan -- administration & dosage
- Uterine Cervical Neoplasms -- drug therapy
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.